Basal cell carcinoma (BCC) is the most common malignant tumour in white populations.
Multidisciplinary experts from the European Dermatology Forum, the European Association …

Non-melanoma skin cancers (NMSCs) include basal cell carcinoma (BCC), squamous cell
carcinoma (SCC) and Merkel cell carcinoma (MCC). These neoplasms are highly diverse in …

Basal cell carcinoma (BCC) is the most common human cancer worldwide, and is a subtype
of nonmelanoma skin cancer, characterized by a constantly increasing incidence due to an …

Background Patients with advanced basal cell carcinoma have limited treatment options.
Hedgehog pathway signalling is aberrantly activated in around 95% of tumours. We …

Skin cancer is a worldwide, emerging clinical need in the elderly white population, with a
steady increase in incidence rates, morbidity and related medical costs. Skin cancer is a …

Sonidegib and vismodegib are hedgehog pathway inhibitors (HhIs) approved for the
treatment of advanced basal cell carcinoma (BCC). Until recently, vismodegib was the only …

Basal cell carcinomas are the most frequent skin cancers in the fair-skinned adult population
over 50 years of age. Their incidence is increasing throughout the world. Ultraviolet (UV) …

Background The hedgehog pathway inhibitor sonidegib demonstrated meaningful tumor
shrinkage in more than 90% of patients with locally advanced basal cell carcinoma (BCC) or …

For the treatment of superficial basal cell carcinoma, a prospective, noninferiority,
randomized controlled multicenter trial with 601 patients showed that 5% imiquimod cream …

Background Skin diseases constitute up to 40% of all notified occupational diseases in most
European countries, predominantly comprising contact dermatitis, contact urticaria, and skin …